Parallel Advisors, LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Parallel Advisors, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$144.95 - $152.29 $1,884 - $1,979	13 Added 43.33%	43 $7,000
Q2 2022 Aug 01, 2022	SELL	$83.14 - $145.99 $83 - $145	-1 Reduced 3.23%	30 $4,000
Q1 2022 Apr 28, 2022	BUY	$110.08 - $142.92 $660 - $857	6 Added 24.0%	31 $4,000
Q4 2021 Jan 20, 2022	SELL	$99.73 - $148.48 $10,870 - $16,184	-109 Reduced 81.34%	25 $3,000
Q3 2021 Nov 02, 2021	BUY	$98.85 - $138.91 $11,466 - $16,113	116 Added 644.44%	134 $19,000
Q2 2020 Jul 16, 2020	BUY	$29.01 - $74.23 $522 - $1,336	18 New	18 $1,000

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.8B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Parallel Advisors, LLC with notifications on news.